Open site navigation

NovaXS' Current Partnership

NovaXS is preparing an IRB clinical study at University of Illinois, Chicago Infertility Center in December 2022. 9 IVF centers in Southern California are committed to distribute NovaXS’ needle-free solution and integrate the EHR with the Patient APP once the device receives FDA approval.

The in-vitro fertilization process for women are not as desirable as the result. Within a cycle of 4 months, women are required to receive 148 total injections mixed with 4 different kinds of medications and 7 distinctive treatment schedules. Specifically, delivering viscous Progesterone Oil intramuscularly gives patients a nightmare. Telosis is the one-stop solution for IVF patients to simplify the self-administration process and improve treatment outcome.

Needle-free Device

Better
Results

Ease
of use

Effortless
& Painless